Optimization of Hsp90/Aha1 Small-Molecule Disruptors Via the Evaluation of Amide Bioisosteres
Recent structure-activity relationships (SAR) were established around KU-177, the parent scaffold for an Hsp90/Aha1 small-molecule disruptor, which suggested that the central amide linker adopted a <i>cis</i>-amide conformation for the inhibitory activity. In this Letter, a series of analogues was synthesized to contain various amide bioisosteres, which were evaluated for their ability to disrupt Hsp90/Aha1 interactions. The inhibitory activity was determined with recombinant protein as well as co-immunoprecipitation experiments with cell lysates. The most efficacious scaffolds were assessed for solubility, metabolic stability, and permeability, where the most efficacious molecule was the sulfonamide-containing compound <b>44</b>. New molecules emerged from this study and will be optimized in subsequent SAR campaigns.
Authors
- Brian S. J. Blagg (ORCID: https://orcid.org/0000-0002-6200-3480)
- Bradley M. Keegan (ORCID: https://orcid.org/0000-0003-0457-4493)
- Kevin Catalfano
Institutions
- University of Notre Dame (US)
- Discovery Laboratories (United States) (US)
- Drug Discovery Laboratory (Norway) (NO)
- Center for Discovery (US)
Publication Details
- Journal
- ACS Medicinal Chemistry Letters
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1021/acsmedchemlett.5c00592
- Primary Topic
- Heat shock proteins research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Alzheimer's Drug Discovery Foundation
- University of Notre Dame